Gabapentin enacarbil is not currently available as a generic medication. As of late 2023, it remains under patent protection [1].
When Does Gabapentin Enacarbil Patent Protection End?
The patent exclusivity for gabapentin enacarbil is expected to end in 2025 [1]. This means that generic versions of the drug could become available after this date.
What is Gabapentin Enacarbil Used For?
Gabapentin enacarbil is prescribed to treat restless legs syndrome (RLS) in adults [2]. It is taken once daily for the treatment of moderate-to-severe primary RLS [2].
How Does Gabapentin Enacarbil Work?
Gabapentin enacarbil is a prodrug of gabapentin. Once absorbed, it is rapidly converted to gabapentin in the body [2]. Gabapentin is thought to work by affecting the activity of certain neurotransmitters in the brain that are involved in controlling movement [2].
What Are the Risks Associated with Gabapentin Enacarbil?
Common side effects of gabapentin enacarbil include dizziness, sleepiness, and fatigue [2]. More serious potential risks include allergic reactions, suicidal thoughts or behavior, and central nervous system effects [2]. Patients should discuss any concerns about side effects with their healthcare provider.
Are There Alternatives to Gabapentin Enacarbil for Restless Legs Syndrome?
Other treatments for restless legs syndrome exist, depending on the severity and cause of the condition. These can include lifestyle changes, iron supplements if there is a deficiency, dopamine agonists, and other anticonvulsant medications [3].
Where Can I Find More Information on Drug Patents?
Information on drug patents, including expiry dates, can be found on DrugPatentWatch.com [1].
---
Sources:
1. https://drugpatentwatch.com/
2. Information regarding gabapentin enacarbil's use and side effects.
3. Information regarding alternative treatments for restless legs syndrome.